The Global Oncology Small Molecule Drugs Market is experiencing steady expansion, driven by the increasing global burden of cancer and advancements in targeted cancer therapies. According to market estimates, the industry is projected to grow at a CAGR of 5.6% from 2025 to 2031 , reflecting consistent demand for effective, oral, and cost-effective cancer treatment options. The market continues...